These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9442782

  • 21. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.
    Rácz P, Ruzsonyi MR, Nagy ZT, Gaygi Z, Bito LZ.
    Arch Ophthalmol; 1996 Mar; 114(3):268-73. PubMed ID: 8600885
    [Abstract] [Full Text] [Related]

  • 22. Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial.
    Higginbotham EJ, Feldman R, Stiles M, Dubiner H, Fixed Combination Investigative Group.
    Arch Ophthalmol; 2002 Jul; 120(7):915-22. PubMed ID: 12096962
    [Abstract] [Full Text] [Related]

  • 23. A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension.
    Susanna R, Giampani J, Borges AS, Vessani RM, Jordao ML.
    Ophthalmology; 2001 Feb; 108(2):259-63. PubMed ID: 11158796
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
    Weinreb RN, Scassellati Sforzolini B, Vittitow J, Liebmann J.
    Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
    [Abstract] [Full Text] [Related]

  • 30. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
    Simmons ST, Earl ML, Alphagan/Xalatan Study Group.
    Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of single glaucoma medication in combined latanoprost and timolol XE therapy in patients with open-angle glaucoma and ocular hypertension: a discontinuation study.
    Kobayashi H.
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):387-91. PubMed ID: 22335426
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH, Feldman RM, Sheu WP, Fixed Combination Latanoprost/Timolol Study Group.
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study.
    Uusitalo H, Pillunat LE, Ropo A, Phase III Study Investigators.
    Acta Ophthalmol; 2010 Feb; 88(1):12-9. PubMed ID: 20420586
    [Abstract] [Full Text] [Related]

  • 34. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T, Chew PT, Yip CC, Chan YH, See JL, Khng CG, Hoh ST, Ng LH, Lee HM.
    Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
    [Abstract] [Full Text] [Related]

  • 35. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK, Tressler CS, United States Fixed-Combination Study Group.
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [Abstract] [Full Text] [Related]

  • 36. Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy.
    Varma R, Hwang LJ, Grunden JW, Bean GW.
    Br J Ophthalmol; 2010 Jan; 94(1):80-4. PubMed ID: 19692375
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.